Serum C-reactive protein in acute biliary pancreatitis. Is it a reliable marker for the early assessment of severity of the disease?

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 6, 1997, Pages 554-557

  Pezzilli, R ^a   Billi, P ^a   Cappelletti, O ^a   Barakat, B ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute biliary pancreatitis; C reactive protein; Severe acute pancreatitis

Indexed keywords

C REACTIVE PROTEIN;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PANCREATITIS; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT DISEASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; PROBABILITY; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0031410359     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pepys MB. C reactive protein fifty years on. Lancet 1981;l:653-7.
2. Gewürz H. C reactive protein levels in disease. Adv Intern Med 1982;27:345-77.
3. Morley JJ, Kushner I. Serum C reactive protein levels in disease. AnnAcadSci 1982;139:406-15.
4. Ghoneim AT, Howarths H, lonescu MI. Serial C reactive protein measurements in infective complications following cardiac operation evaluation and use in monitoring response to therapy. Ann Thorac Surg 1982;34:166-75.
5. Mayer AD, McMahon MJ, Bowen M, Cooper EH. C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J ClinPathol 1984;37:207-11.
6. Agarwal N, Pitchumoni CS. Assessment of severity in acute pancreatitis. Am J Gastroenterol 1991:86:1385-91.
7. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
8. Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG. PNMelastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991;6:253-9.
9. Marek T, Nowak A, Dziurkowska-Marek A, Nowakowska-Dulawa E, Kaczor R, Cholewka A. C-reactive protein (CRP) in the early prognosis of outcome in acute biliary pancreatitis (ABP). Gut 1995;37(Suppl 2):A221.
10. Pezzilli R, Billi P, Plate L, Barakat B, Bongiovanni F, Miglioli M. Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis. A comparison with C-reactive protein. J Clin Gastroenterol 1994; 19:112-7.
11. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11-13, 1992. Arch Surg 1993:128:586-90.
12. Pezzilli R, Billi P, Minière R, Fiocchi M, Cappelletti O, Morselli Labate AM, et al. Serum interleukin 6, interleukin 8 and 2 mi-croglobulin in the early assessment of the severity of acute pancreatitis. A comparison with serum C-reactive protein. Dig Dis Sei 1995;40:2341-8.
13. Pezzilli R, Billi P, Barakat B, Baroncini D, D'lmperio N, Miglio F. Effect of early ductal decompression in human acute pancreatitis. Pancreas 1998, (in press).
14. Neoptolemos JP, London NJ, James D, Carr-Locke DL, Bailey IA, Fossard DP. Controlled trial of endoscopie sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988;l:979-83.
15. Schulz HU, Schmidt D, Kunz D, Meyer F, Lippert H. Altered immune function in acute pancreatitis: pathogenetic role and prognostic indicator? Digestion 1993;54:307-8.
16. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-8.
17. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-5.
18. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase pro-tein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
19. Gross V, Andreesen R, Leser HG, Ceska M, Liehl E, Lausen M. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22:200-3.
20. Pezzilli R, Billi P, Gullo L, Beltrandi E, Maidini M, Mancini R, et al. Behavior of serum soluble interIeukin-2 receptor, soluble CDS and soluble CD4 in the early phases of acute pancreatitis. Digestion 1994;55:268-73.
21. Pezzilli R, Billi P, Plate L, Bongiovanni F, Morselli Labate AM, et al. Human pancreas-specific protein/procarboxypeptidase B: a useful serum marker of acute pancreatitis. Digestion 1994;55:73-7.
22. Le J, Vilcek J. Biology of disease. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989;61:588-602.
23. Messori A, Rampazzo R, Scroccaro G, Olivato R, Bassi C, Falconi M, et al. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. Dig Dis Sei 1995;40:734-8.
24. Leder PC. Early treatment with Lexipafant, a platelet activating factor (PAF) antagonist, reduces morbidity and mortality from acute pancreatitis: a double blind, randomized, placebo controlled study. Digestion 1997;58 (Suppl 2):8.